Sabe, H., Hashimoto, A., Hashimoto, S., & Oikawa, T. (2016). Tumor responsiveness to statins requires overexpression of the ARF6 pathway. Mol Cell Oncol.
Style de citation ChicagoSabe, Hisataka, Ari Hashimoto, Shigeru Hashimoto, et Tsukasa Oikawa. "Tumor Responsiveness to Statins Requires Overexpression of the ARF6 Pathway." Mol Cell Oncol 2016.
Style de citation MLASabe, Hisataka, Ari Hashimoto, Shigeru Hashimoto, et Tsukasa Oikawa. "Tumor Responsiveness to Statins Requires Overexpression of the ARF6 Pathway." Mol Cell Oncol 2016.
Attention : ces citations peuvent ne pas être correctes à 100%.